# FDA Inspection 892232 - Rx Compounding Inc. - August 21, 2014

Source: https://www.keypedia.com/records/fda_inspections/rx-compounding-inc/1ec1b0fa-c7c4-497e-9625-04baa0fde6aa
Source feed: FDA_Inspections

> FDA Inspection 892232 for Rx Compounding Inc. on August 21, 2014. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 892232
- Company Name: Rx Compounding Inc.
- Inspection Date: 2014-08-21
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 832980 - 2013-05-15](https://www.keypedia.com/records/fda_inspections/rx-compounding-inc/1fbc0c5f-63c4-4ad9-924e-39f51a4e9d92)
- [FDA Inspection 823199 - 2013-03-21](https://www.keypedia.com/records/fda_inspections/rx-compounding-inc/9c6a63cd-06d2-4507-bbd5-429e2b2574ef)
- [FDA Inspection 823199 - 2013-03-21](https://www.keypedia.com/records/fda_inspections/rx-compounding-inc/8fe5158a-d32e-474a-98ce-7b1891784a78)

Company: https://www.keypedia.com/companies/rx-compounding-inc/7455ac76-39f4-4a99-8519-b2b93516fdb6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c